Half-life estimate, not bloodwork or dosing advice. Disclaimer.
MK-677. Oral ghrelin-receptor agonist. No human PK study has been published, so the half-life is an estimate; at daily dosing most of each dose clears before the next. There is no ester, so the line is the dose itself. Also called Ibutamoren, MK 677, Mk677. The half-life is an estimate. Methodology.
| Half-life | 6h |
|---|---|
| Time to peak | 5h |
| Parent hormone | 100% |
| Example input | 25 mg |
| Example frequency | every day |
| Example length | 8 weeks |
| Data quality | Low |
No primary human PK is published. A review gives 5–6 h (Sinha et al. 2020) and a trial protocol 8 h (NCT05364684); modeled as 6 h. Tmax is an estimate. How the model works.
25 mg every day for 8 weeks. With a 6h half-life, it levels off around day 2. The row runs longer than that, so the plateau is on the chart. Between doses it runs from about 2.9 to 26.7 mg, a swing of 89%. Each dose is its own spike. After the last dose, the tail takes about 1.5 days to fall to a few percent.